Chandra Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.25 Cr
as on 24-10-2024
- Paid Up Capital ₹ 4.25 Cr
as on 24-10-2024
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.55 Cr
as on 24-10-2024
- Satisfied Charges ₹ 1.70 M
as on 24-10-2024
- Revenue 16.87%
(FY 2023)
- Profit 34.73%
(FY 2023)
- Ebitda -23.45%
(FY 2023)
- Net Worth 15.51%
(FY 2023)
- Total Assets 37.56%
(FY 2023)
About Chandra Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.25 Cr and a paid-up capital of Rs 4.25 Cr.
The company currently has active open charges totaling ₹5.55 Cr. The company has closed loans amounting to ₹1.70 M, as per Ministry of Corporate Affairs (MCA) records.
Bandi Satyanarayana, Sridhana Bandi, Sivarama Mulpury, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232TG2007PTC055152
- Company No.
055152
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Chandra Life Sciences Private Limited offer?
Chandra Life Sciences Private Limited offers a wide range of products and services, including Speciality Chemicals.
Who are the key members and board of directors at Chandra Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bandi Satyanarayana  | Managing Director | 17-Aug-2007 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sridhana Bandi | Director | 28-Mar-2019 | Current |
| Sivarama Mulpury | Director | 28-Mar-2019 | Current |
| Mannam Rao | Director | 18-Mar-2022 | Current |
| Sundeep Bandi | Additional Director | Current |
Financial Performance of Chandra Life Sciences.
Chandra Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.87% increase. The company also saw a substantial improvement in profitability, with a 34.73% increase in profit. The company's net worth Soared by an impressive increase of 15.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chandra Life Sciences?
In 2023, Chandra Life Sciences had a promoter holding of 79.85% and a public holding of 20.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Corporation Bank Creation Date: 29 Jun 2009 | ₹5.55 Cr | Open |
Axis Bank Limited Creation Date: 03 Oct 2020 | ₹1.70 M | Satisfied |
How Many Employees Work at Chandra Life Sciences?
Chandra Life Sciences has a workforce of 38 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chandra Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chandra Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
